Customize your JAMA Network experience by selecting one or more topics from the list below.
Author Affiliations: Divisions of General Pediatrics (Dr Butz) and Allergy and Immunology (Drs Matsui and Eggleston and Ms Curtin-Brosnan), Department of Pediatrics, and Department of Pulmonary and Critical Care (Drs Diette and Rand), The Johns Hopkins University School of Medicine, and Department of Environmental Health Sciences, The Johns Hopkins University Bloomberg School of Public Health (Drs Breysse and Williams and Mr Yuan), Baltimore, Maryland; and Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia (Dr Bernert).
Objective To test an air cleaner and health coach intervention to reduce secondhand smoke exposure compared with air cleaners alone or no air cleaners in reducing particulate matter (PM), air nicotine, and urine cotinine concentrations and increasing symptom-free days in children with asthma residing with a smoker.
Design Randomized controlled trial, with randomization embedded in study database.
Settings The Johns Hopkins Hospital Children's Center and homes of children.
Participants Children with asthma, residing with a smoker, randomly assigned to interventions consisting of air cleaners only (n = 41), air cleaners plus a health coach (n = 41), or delayed air cleaner (control) (n = 44).
Main Outcome Measures Changes in PM, air nicotine, and urine cotinine concentrations and symptom-free days during the 6-month study.
Results The overall follow-up rate was high (91.3%). Changes in mean fine and coarse PM (PM2.5 and PM2.5-10) concentrations (baseline to 6 months) were significantly lower in both air cleaner groups compared with the control group (mean differences for PM2.5 concentrations: control, 3.5 μg/m3; air cleaner only, −19.9 μg/m3; and air cleaner plus health coach, −16.1 μg/m3; P = .003; and PM2.5-10 concentrations: control, 2.4 μg/m3; air cleaner only, −8.7 μg/m3; and air cleaner plus health coach, −10.6 μg/m3; P = .02). No differences were noted in air nicotine or urine cotinine concentrations. The health coach provided no additional reduction in PM concentrations. Symptom-free days were significantly increased in both air cleaner groups compared with the control group (P = .03).
Conclusion Although the use of air cleaners can result in a significant reduction in indoor PM concentrations and a significant increase in symptom-free days, it is not enough to prevent exposure to secondhand smoke.
Trial Registration clinicaltrials.gov Identifier: NCT00466024
More than 30% of US children are exposed to secondhand smoke (SHS) in their homes,1,2 with rates as high as 40% to 46% of children living in poverty.3 Despite parental awareness that SHS exacerbates asthma, 40% to 67% of inner-city children with asthma reside in a household with at least 1 smoker.4,5 Accordingly, avoidance of SHS exposures is a key recommendation of national and international asthma guidelines.6 Smoking is the dominant contributor to indoor particulate matter (PM) levels, increasing fine PM concentrations (PM2.5) by up to 25 to 45 μg/m3, compared with the 3- to 6-μg/m3 increase associated with indoor sweeping or cooking.7-9 Tobacco smoke is a complex mixture consisting of a gas-vapor phase and a particulate phase containing more than 4000 individual chemical constituents.10,11 Reduction in PM concentrations of SHS exposures with the use of air cleaners has been reported12-15; however, the data have been deemed insufficient to recommend the use of indoor air-cleaning devices to alleviate asthma symptoms.16
Total home smoking bans are difficult to sustain in inner-city families.4 Moreover, inner-city children often reside in multiunit housing that may predispose them to higher SHS exposure via shared common spaces and ventilation systems with households with smokers.17 Based on the success of a behavioral SHS reduction intervention that reduced air nicotine levels18 and previous reports of reduction in PM concentration with the use of air cleaners,12-15 we hypothesized that the combination of air cleaners with a behavioral intervention promoting home smoking bans would reduce levels of PM, air nicotine, and urine cotinine and reduce asthma morbidity in inner-city children with asthma who reside with a smoker compared with children receiving air cleaners alone or a control condition of no air cleaners or behavioral intervention.
This randomized 3-arm controlled trial, the Particulate Reduction Education in City Homes (PREACH) study, was reviewed and approved by The Johns Hopkins Medical Institutional Review Board and registered with clinicaltrials.gov (NCT00466024). Written informed consent was obtained from the child's primary caregiver. All clinic and laboratory staff were masked to group assignment during recruitment and follow-up. Participants were randomized in a 1:1:1 ratio with random block sizes. Randomization was performed by the study coordinator, who activated a randomization function embedded in the study database. All study staff, including all investigators, were blinded to subsequent group assignment. All participants agreed to attend 2 clinic and home visits for data collection at baseline and 6-month follow-up. During each clinic visit, the caregiver was administered a questionnaire, and urine samples were obtained from each child for cotinine analysis as a biomarker of SHS exposure. Home indoor air quality assessments were conducted by trained home indoor monitoring technicians within 2 weeks of the child's baseline and 6-month follow-up clinic visits. Laboratory staff who processed biological and environmental samples were blinded to study assignments.
The names of 1462 potentially eligible children diagnosed as having asthma were obtained from patient rosters of 1 urban pediatric emergency department and 2 community pediatric practices from October 1, 2006, through December 31, 2008. Letters were mailed to caregivers of children with asthma to set up screening appointments. Owing to inaccurate diagnoses and inaccurate age, address, and telephone information noted in medical records, only 189 children were available for screening and recruitment, and 126 children (66.7%) were enrolled and randomized. Most children were recruited during the fall season with no differences noted by group for season of recruitment. Eligibility criteria included child age of 6 to 12 years; physician-diagnosed asthma, symptom frequency, and/or controller medication use signifying persistent asthma6; a smoker in the home who smoked more than 5 cigarettes per day and resided in the home at least 4 days per week; and residence in the Baltimore metropolitan area. Several attempts were made to contact all potentially eligible participants by telephone, with at least 10 attempts made at varying times and days.
Families randomized to the control group received asthma education during 4 nurse home visits as an attention control group. Asthma education included review of asthma medications, spacer and peak flow techniques, development of an asthma action plan, and provision of written asthma education materials. Two high-efficiency particle air (HEPA) cleaners were placed in the child's home (bedroom and living room) after the final follow-up home-monitoring visit. The HEPA air cleaners (Holmes Harmony Air Purifier HAP650; Holmes, a subsidiary of Jarden Corporation, Rye, New York) were 48 × 27 × 61-cm (19 × 10.63 × 24-in) units with an activated carbon filter, a pleated HEPA filter, 4 speeds, a clean air delivery rate of 225, and a recommended cleaning area of 10.8 m2 (342 ft2) (a room 5.4 × 5.7 m [18 × 19 ft]). The mean (SD) area of the study homes was 54.9 (18.6) m2 (610  ft2), and the average bedroom area was 10.8 m2 (120 ft2) (3.0 × 3.6 m [10 × 12 ft]). Families were instructed to run the air cleaners continuously using the medium speed.
Families randomized into the air cleaner group received 2 air cleaners and the 4 asthma education sessions described in the previous section. Air cleaners were placed in the bedroom where the child slept 4 or more nights per week and in the family television or living room. Families who relocated during the study intervention underwent reevaluation for indoor air quality at the new residence.
Families randomized to the air cleaner plus health coach behavioral intervention group received the 2 air cleaners and four 30- to 45-minute nurse health coach home visits that included the asthma education described in the previous sections and a behavioral intervention. All health coach visits were completed within 2 months of randomization. The SHS behavioral intervention was a modified motivational health coach SHS reduction program for low-income families18 with the following 5 core components: (1) identify the child's SHS exposure risk, (2) assess the caregiver's motivation and readiness for behavior change, (3) set an SHS–home smoking ban goal with the caregiver for which the caregiver signs a contingency contract for established behavior change, (4) encourage and monitor the use of air cleaners, and (5) teach the child SHS avoidance techniques. The nurse interventionist received ongoing weekly supervision to review successes and difficulties in implementing the health coach protocol.
The child's SHS exposure in the home was based on the caregiver's self-report of smoking frequency and location in the home, number of cigarettes smoked inside and outside the home, and the number of quit attempts during the caregiver's lifetime. Exposure to SHS was limited to the child's primary household of 5 or more days each week. The caregiver's report of success in keeping the child away from cigarette smoke was measured using a 4-point Likert scale ranging from not at all to very successful. The total number of hours spent indoors per day during the past 7 days was based on the caregiver's report.
Urine cotinine has a half-life of 16 to 20 hours in children,19 reflecting SHS exposure up to 24 hours after exposure.20 Urine samples (30 mL) were obtained from each child at baseline and 6 months and sent to the Centers for Disease Control and Prevention laboratories for analysis. Urine aliquots were fortified with trideuterated cotinine and hydrolyzed overnight with β-glucuronidase, after which the samples were extracted and the total cotinine concentration was measured by liquid chromatography/atmospheric pressure ionization and tandem mass spectrometry.19,20 All reported data are from runs confirmed as being in statistical control based on standard criteria.21 Cotinine results are reported as nanograms per milliliter with a limit of detection (LOD) of 0.036 ng/mL. All cotinine values were above the LOD. Cotinine values of greater than 6.2 ng/mL were considered positive for SHS exposure.22
Environmental assessment of indoor air quality, the primary outcome, consisted of air sampling for fine and coarse PM (PM2.5 and PM 2.5-10, respectively) and air nicotine concentrations. Air sampling was conducted in the child's bedroom and living room or television room because these rooms represent an indoor environment where the child spends a substantial portion of time. Continuous air sampling was conducted during the 7 days, within 2 weeks of clinic visit, using PM10 and PM2.5 4-L/min impactors (MSP Corp, St Paul, Minnesota) loaded with 37-mm, 2.0-μm pore size, Teflon polytetrafluoroethylene membrane filters with polypropylene support rings (Pall Corporation, Ann Arbor, Michigan). The PM2.5 concentrations reflect particles with an aerodynamic diameter of less than 2.5 μm that are capable of deposit in the lower airways. The 24-hour US Environmental Protection Agency (EPA) ambient PM2.5 air quality standard23 is 35 μg/m3. The PM2.5-10 fraction, coarse PM, was calculated as the difference between particles with an aerodynamic diameter of 10 and 2.5 μm, as a measure of particles deposited primarily in the upper and larger airways.24 The EPA does not regulate coarse PM fraction, and no threshold is available.
A passive sampling badge was placed in the child's bedroom at 0.9 to 1.5 m (3-5 ft) above the floor. The passive air samplers consist of a sodium bisulfate–treated filter contained in a 37-mm polystyrene cassette covered with a polycarbonate filter diffusion screen.25 Nicotine content was analyzed using gas chromatography with a nitrogen phosphate detector. The LOD for the passive air nicotine badges was 0.003 μg/m3. All nicotine levels were above the LOD. We defined air nicotine levels greater than the LOD as positive for indoor SHS exposure.
Frequency of symptom days and nights were based on caregiver responses to the items “In the past 2 weeks, how many days did [child] have wheezing, coughing, shortness of breath, or tightness in the chest?” and “In the past 2 weeks, how many nights did [child] wake up with cough, wheeze, shortness of breath, or chest tightness?” A response of greater than 0 on either question was counted as a symptom day. In addition, the number of slowed-activity days owing to asthma was ascertained at the baseline and 6-month interviews. Asthma severity was based on day and night symptom frequency during the past 2 weeks and the number of emergency department visits and hospitalizations in the past 6 months.6 Acute health care utilization was based on report of any emergency department or urgent care visit or hospitalization at baseline or the 6-month follow-up visit.
Adherence to HEPA air cleaner use was measured in a subset of 13 households using data loggers or current meters (HOBO; MicroDAQ.com, LTD, Contoocook, New Hampshire). The meters, inserted inside the air cleaner to avoid child tampering, sense the change in electric current associated with turning the air cleaners on and off. The data loggers recorded the time and date for each on and off event. Families with adherence monitors were informed that air cleaner use was monitored.
Sample size estimates indicated that 40 participants in each of the 3 groups would provide 80% power at an α of .05 to detect a 50% difference in PM concentrations between any pair of groups.
Baseline characteristics were compared across the groups using χ2 tests for categorical variables, the Kruskal-Wallis test for nonnormally distributed continuous variables, and analysis of variance for age, which was normally distributed. Differences in exposure outcomes from baseline to 6 months were calculated and compared across the 3 treatment groups using the Kruskal-Wallis test because the differences in the exposure outcomes were right-skewed and not normally distributed. We then combined both air cleaner groups for comparison with the control group and used the Mann-Whitney test for comparison between these 2 groups. Symptom-free days (SFDs) were calculated for the baseline and 6-month measurements by subtracting the number of days of asthma symptoms during a 2-week period from 14 days. The change in SFDs from baseline to 6 months was calculated and compared across the 3 treatment groups using paired, 2-tailed t tests because the data were normally distributed. Days without slowed activity due to asthma were examined using the same approach used for SFDs. Logistic regression was used to model the relationship between acute asthma health care utilization and treatment group. A 2-sided α < .05 was considered statistically significant. All analyses were performed using commercially available software (Stata version 11.0; StataCorp, College Station, Texas).
Of the 189 families screened and recruited, 126 (66.7%) consented to participate. All 126 (100.0%) completed the baseline questionnaire and were randomly assigned to the control, air cleaner, or air cleaner plus health coach groups (Figure 1). At the 6-month follow-up, 115 families (91.3%) completed questionnaire data, and high rates of interpretable air monitoring and urine cotinine data were available (PM2.5 levels, 83.3%; PM2.5-10 levels, 80.1%; air nicotine levels, 90.4%; urine cotinine levels, 96.0%). Most children were male (54.8%), African American (96.8%), and enrolled in Medicaid (89.7%) and lived with their biological mother (81.0%) (Table 1). The mean age of the children was 9.1 years. Asthma severity was high, with 79.4% children categorized as having persistent asthma (mild, 16.7%; moderate, 31.7%; and severe, 31.0%). Most children reported albuterol use within the past 2 weeks. There were no group differences for sociodemographic or health characteristics, with the exception of a slightly lower percentage of African American children in the control group and a fewer number of SFDs for the air cleaners plus health coach group (Table 1). There were no differences by child age, race/ethnicity, sex, or Medicaid status between the participants completing the follow-up and those unavailable for follow-up. Baseline mean PM2.5, air nicotine, and urine cotinine concentrations are given in Table 1.
Figure 1. Participant recruitment and retention flowchart.
The caregiver was the predominant household smoker at baseline (68.3%) and follow-up (60.9%), a finding that did not differ by group. Children randomized into the control group had caregivers who smoked significantly more cigarettes at baseline and follow-up compared with children in either air cleaner group. Caregivers reported a median of 2 quit attempts during their lifetime at baseline, and attempts did not differ by air cleaner group. Almost one-half (46.0%) of caregivers reported smoking in their bedroom at baseline, which decreased to 30.4% at follow-up but did not differ by group (Table 2). Children spent most time indoors (mean, 20.3 h/d), and differences of time spent indoors between baseline and 6 months did not differ by group (P = .90). Success in keeping their child away from cigarette smoke was reported by a significantly higher number of caregivers in the air cleaner groups at follow-up (Table 2). Almost all caregivers reported at baseline and follow-up that they tried keeping their child away from cigarette smoke (baseline, 98.4%; follow-up, 100.0%).
At follow-up, both air cleaner groups had significant decreases in mean differences in PM2.5 and PM2.5-10 concentrations, whereas the control PM concentrations remained unchanged (Table 3). The health coach provided no additional reduction in PM concentrations when we compared the 2 air cleaner groups (Table 3). Comparison of the combined air cleaner groups and the control group indicated that the combined air cleaner groups had significant mean differences in PM2.5 and PM2.5-10 levels from baseline to follow-up (mean differences for PM2.5: control, 3.5 [SD, 20.0]; combined air cleaner groups, −18.0 [SD, 33.2; P < .001]; and for PM2.5-10: control, 2.4 [SD, 20.8]; combined air cleaner groups, −9.6 [SD, 16.0; P = .009]) (Figure 2). No significant differences were noted in air nicotine or urine cotinine concentrations between baseline and follow-up by group (Table 3). Adherence to air cleaner use was moderate, with air cleaner use logged at a mean of 106.7 (SD, 52.5) of 180 days (59.3%) in the subset of households with data loggers.
Figure 2. Box plots for mean differences in fine (aerodynamic diameter of <2.5 μm) and coarse (difference between particles with an aerodynamic diameter of 10 and 2.5 μm) particulate matter (PM2.5 and PM2.5-10, respectively) concentrations from the 6-month follow-up, minus the baseline concentrations in the control compared with both air cleaner groups. We used the Mann-Whitney test to compare the change in PM concentrations between groups. The horizontal line in the middle of each box indicates the median, while the top and bottom borders of the box mark the 75th and 25th percentiles, respectively. The whiskers above and below the box mark the maximum and minimum values or 1.5 times the interquartile range. The points beyond the whiskers are outliers.
The air cleaner plus health coach group reported the highest increase in SFDs between baseline and 6 months, although this did not reach statistical significance (P = .09) (Table 4). Differences in SFDs for slowed activity or night symptoms did not differ by group between baseline and follow-up. After combining the air cleaner groups, children assigned to those groups had a significant increase in SFDs during the past 2 weeks (1.36 SFDs) compared with 0.24 SFDs for control group children from baseline to follow-up. A trend of having an increase in slowed-activity SFDs was noted in the air cleaner groups compared with the control group (air cleaner groups, 1.76 SFDs; control group, 0.25 SFDs [P = .06]). There were no differences between the combined air cleaner groups compared with the control group at follow-up for symptom-free nights (P = .14) or for any acute asthma health care event during the past 6 months (odds ratio, 1.3; 95% confidence interval, 0.6-2.9).
Use of air cleaners in the homes of children with asthma residing with a household smoker significantly diminished fine and coarse PM concentrations compared with homes with no air cleaners. Moreover, children residing in homes with air cleaners experienced a significant increase in SFDs (1.36 in 2 weeks), yielding an additional 33 SFDs per year. Because smoking is a dominant contributor to indoor fine PM levels26 and increases PM2.5 levels by 25 to 45 μg/m3,7,8,26 the reduction of 16 to 20 μg/m3 in PM2.5 levels in homes with air cleaners at 6 months indicates a significant reduction in fine particles in these homes, although not to the concentrations reported in children residing in homes without smokers27 or below the 24-hour EPA standards for outdoor air quality (35 μg/m3).23 However, our reductions in PM2.5 concentrations were similar to those of other studies of inner-city homes of children with asthma exposed to SHS.28,29
The addition of an intensive health coach intervention provided no additional reduction in PM concentrations or health effects compared with the air cleaner–only group and is in contrast to previous randomized controlled trials of behavioral SHS reduction interventions.17,30-32 Our primary focus for the health coach was tailoring the SHS reduction intervention to the parents' readiness and motivation for SHS reduction in the home. However, many caregivers reportedly fail to achieve smoking cessation.18 Moreover, caregivers in the control and air cleaner plus health coach groups had a poor perception of their child's exposure to SHS, based on the discordance between caregiver report of high success in keeping their child away from SHS and the follow-up PM concentrations at or above US EPA 24-hour standards.
Use of the air cleaners was not associated with significant reductions in air nicotine or urine cotinine concentrations, although mean concentrations were high (air nicotine, >0.003 μg/m3; urine cotinine, >6.2 ng/mL). The air cleaners may have been less effective in reducing the gas-vapor nicotine than they were in reducing PM. Although the air filters used in this study included a charcoal filter to remove certain gaseous contaminants and a HEPA filter to remove particulate contaminants, charcoal has been suggested to be a poor nicotine absorbent.33,34 Thus, the improvement in symptoms was most likely associated with the reduction in PM concentrations rather than with the reduction in nicotine exposure, consistent with other reports35 suggesting that the nonnicotine particle-bound components of tobacco smoke are the major contributors to increased risk of systemic inflammatory diseases.
Furthermore, the significant improvement in health effects was most likely associated with the significant reduction in PM levels owing to air cleaner placement compared with a change in household smoking behavior. McCormack et al36 noted a 6% increase in the number of days of cough, wheeze, or chest tightness for every 10-μg/m3 increase in indoor coarse PM levels in a comparable sample of preschool children with asthma. Deposition of coarse PM in the airways and subsequent bronchial hyperreactivity may be the underlying mechanism for respiratory symptoms.26,36 Our rate of increase of 33 SFDs/y was comparable to the number of SFDs reported in previous inner-city asthma studies that also used HEPA air cleaners in homes with smokers, pets, or mold problems37 but higher than the number of SFDs achieved in a clinic- and home-based asthma educational and family support intervention.38 The 14% to 18% increase in SFDs observed in our study is similar to the 20% increase seen in a clinical trial39 of leukotriene modifiers but less costly. Our data suggest that use of 2 HEPA air cleaners at a retail cost of approximately $200 to $400 may have an efficacy similar to that of leukotriene modifiers, at an approximate cost of $1200 to $1500 per year.40
Our study has a number of limitations. Room size, number of windows, air volume, and ventilation of the household were not measured and may have influenced the follow-up PM and air nicotine levels. Adherence to air cleaner use was not objectively measured in all homes, but in a subset, air cleaner use was moderate at more than half the study days. In addition, we were unable to account for all SHS exposures outside the home. We purposely enrolled low-income urban children with asthma who live in homes with adult smokers to detect a difference between intervention groups. However, this limits the generalizability of results to nonurban children or children living in nonsmoking homes. In addition, the modest sample size may limit our findings. Finally, the 6-month follow-up does not allow long-term evaluation of reduction in indoor PM concentrations or the sustainability of air cleaner use in inner-city families.
Use of air cleaners in homes of children with asthma was associated with a significant reduction in indoor PM concentrations and increase in SFDs. However, the reduced indoor PM levels were not sufficiently decreased to meet EPA standards for outdoor air quality. Although our results indicate that air cleaners are effective at lowering PM concentrations, they are not 100% effective. There is no known threshold for PM-inducing health effects in children with asthma. In addition, it is a tenet of public health practice that eliminating a source of contaminant is better than reducing it through an engineering control. As a result, implementing a smoke-free home policy should be considered, particularly in the homes of children with asthma.
Correspondence: Arlene M. Butz, ScD, MSN, CPNP, Division of General Pediatrics, Department of Pediatrics, The Johns Hopkins University School of Medicine, 200 N Wolfe St, Baltimore, MD 21287 (firstname.lastname@example.org).
Accepted for Publication: February 9, 2011.
Author Contributions: Dr Butz had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Butz, Matsui, Breysse, Eggleston, and Rand. Acquisition of data: Butz, Matsui, Curtin-Brosnan, Eggleston, Diette, Williams, Yuan, and Bernert. Analysis and interpretation of data: Butz, Matsui, Breysse, Curtin-Brosnan, Eggleston, Williams, and Rand. Drafting of the manuscript: Butz, Matsui, Breysse, Curtin-Brosnan, Eggleston, and Yuan. Critical revision of the manuscript for important intellectual content: Butz, Matsui, Breysse, Diette, Williams, and Bernert. Statistical analysis: Matsui and Rand. Obtained funding: Butz, Breysse, and Eggleston. Administrative, technical, and material support: Butz, Breysse, Eggleston, Diette, Williams, Yuan, Bernert, and Rand. Study supervision: Butz and Breysse. Air nicotine analyses: Yuan.
Financial Disclosure: None reported.
Funding/Support: This study was supported by grant E09606 from the National Institute of Environmental Health Science, National Institutes of Health; by grant P01 R-826724 from the Environmental Protection Agency; and by The Johns Hopkins Center for Childhood Asthma in the Urban Environment.
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
Additional Contributions: Craig Lewis and Rooti Lewis, BA, collected the clinical and indoor air data; James E. McGuffey, BS, and Connie S. Sosnoff, MS, performed the urine cotinine analyses.
This article was corrected for errors on August 5, 2011.
Butz AM, Matsui EC, Breysse P, et al. A Randomized Trial of Air Cleaners and a Health Coach to Improve Indoor Air Quality for Inner-City Children With Asthma and Secondhand Smoke Exposure. Arch Pediatr Adolesc Med. 2011;165(8):741–748. doi:10.1001/archpediatrics.2011.111
Browse and subscribe to JAMA Network podcasts!
Create a personal account or sign in to: